Publications by authors named "Alexander Eser"

Claim this Profile
M
Model Informed Precision Dosing Tool Forecasts Trough Infliximab and Associates with Disease Status and Tumor Necrosis Factor-Alpha Levels of Inflammatory Bowel Diseases.
Christian Primas, Walter Reinisch, John C Panetta, Alexander Eser, Diane R Mould

J Clin Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P010 Precision Dosing Tool Forecasts Trough Infliximab and Associates With Disease Status in Inflammatory Bowel Diseases.
Thierry Dervieux, Christian Primas, John Panetta, Diane Mould, Alexander Eser

Am J Gastroenterol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative relationship between infliximab exposure and inhibition of C-reactive protein synthesis to support inflammatory bowel disease management.
Ana-Marija Grisic, Alexander Eser, Wilhelm Huisinga, Walter Reinisch, Charlotte Kloft

Br J Clin Pharmacol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Induction Infliximab Clearance Predicts Early Antidrug Antibody Detection.
Alexander Eser, Walter Reinisch, Stefan Schreiber, Tariq Ahmad, Suliman Boulos

J Clin Pharmacol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Individual Serum Infliximab Concentrations in Inflammatory Bowel Disease by a Bayesian Dashboard System.
Alexander Eser, Christian Primas, Sieglinde Reinisch, Harald Vogelsang, Gottfried Novacek

J Clin Pharmacol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelets Toll-like receptor-4 in Crohns disease.
Werner Schmid, Gottfried Novacek, Harald Vogelsang, Pavol Papay, Christian Primas, Alexander Eser

Eur J Clin Invest· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Guidelines for vaccination of immunocompromised individuals].
Ursula Wiedermann, Harald H Sitte, Heinz Burgmann, Alexander Eser, Petra Falb

Wien Klin Wochenschr· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early recognition of possible pitfalls in histological diagnosis of celiac disease.
Wolfgang Eigner, Friedrich Wrba, Andreas Chott, Kerstin Bashir, Christian Primas, Alexander Eser

Scand J Gastroenterol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohn's Disease: A Randomized Placebo-controlled, Double-blind, Phase IIa Study.
Alexander Eser, Jean-Frederic Colombel, Paul Rutgeerts, Severine Vermeire, Harald Vogelsang

Inflamm Bowel Dis· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased responsiveness to thrombin through protease-activated receptors (PAR)-1 and -4 in active Crohn's disease.
Werner Schmid, Harald Vogelsang, Pavol Papay, Christian Primas, Alexander Eser

J Crohns Colitis· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal insufficiency in IBD--prevalence and possible pathogenetic aspects.
Christian Primas, Gottfried Novacek, Karin Schweiger, Andreas Mayer, Alexander Eser

J Crohns Colitis· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug monitoring of biologics in inflammatory bowel disease.
Alexander Eser, Christian Primas, Walter Reinisch

Curr Opin Gastroenterol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High risk of transfusion-induced alloimmunization of patients with inflammatory bowel disease.
Pavol Papay, Klaus Hackner, Harald Vogelsang, Gottfried Novacek, Christian Primas, Alexander Eser

Am J Med· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of indeterminate IFN-γ release assay in screening for latent TB in inflammatory bowel diseases.
Pavol Papay, Alexander Eser, Stefan Winkler, Sophie Frantal, Christian Primas

Eur J Clin Invest· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors impacting the results of interferon-γ release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases.
Pavol Papay, Alexander Eser, Stefan Winkler, Sophie Frantal, Christian Primas

Inflamm Bowel Dis· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection.
Shomron Ben-Horin, Maya Margalit, Peter Bossuyt, Jochen Maul, Yami Shapira, Alexander Eser

J Crohns Colitis· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection.
Shomron Ben-Horin, Maya Margalit, Peter Bossuyt, Jochen Maul, Yami Shapira, Alexander Eser

Clin Gastroenterol Hepatol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imatinib mesylate inhibits autonomous erythropoiesis in patients with polycythemia vera in vitro.
Leopold Oehler, Eva Jaeger, Alexander Eser, Christian Sillaber, Heinz Gisslinger

Blood· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis